BRIACELL THERAPEUTICS CORP's ticker is and the CUSIP is 10778Y952. A total of 4 filers reported holding BRIACELL THERAPEUTICS CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $445,000 | -18.3% | 712 | -16.0% | 0.33% | -26.7% |
| Q2 2023 | $544,416 | -77.4% | 848 | -73.7% | 0.44% | -78.8% |
| Q1 2023 | $2,404,860 | +44.2% | 3,228 | -15.4% | 2.10% | +43.3% |
| Q4 2022 | $1,667,155 | -47.6% | 3,815 | -32.6% | 1.46% | -63.6% |
| Q3 2022 | $3,181,000 | +10.2% | 5,661 | +13.2% | 4.01% | +104.3% |
| Q2 2022 | $2,886,000 | -56.3% | 5,001 | -23.3% | 1.96% | +99.0% |
| Q1 2022 | $6,610,000 | +85.6% | 6,519 | +51.6% | 0.99% | +90.5% |
| Q4 2021 | $3,561,000 | – | 4,301 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 3,815 | $1,667,155 | 1.46% |
| SIMPLEX TRADING, LLC | 1,800 | $7 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |